Sakar Healthcare (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
Sakar Healthcare Limited |
|||
|
Price: ₹289.80 | ||
| 52 Week Low: ₹279.85 52 Week High: ₹479.00 |
|||
| Market Capital: 586.97 Crore (Smallcap) | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Sakar Healthcare Share Price Target For 2024
- 1.1.1: Sakar Healthcare Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Sakar Healthcare Share Price Target For 2025
- 1.2.1: Sakar Healthcare Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Sakar Healthcare Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Sakar Healthcare Brief Company Overview
- 4: Sakar Healthcare Financial Performance
- 4.0.1: Is Sakar Healthcare A Good Buy For Long Term?
To predict the Sakar Healthcare's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Sakar Healthcare Share Price Target For 2024
The line chart displays the monthly closing prices of Sakar Healthcare with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Sakar Healthcare shares in 2024, see the table below.
Sakar Healthcare Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 304.6 (+5.09%) | Price Action: 16 Aug 2023 Low |
| 2024 Target 2 | 301.55 (+4.05%) | Price Action: 17 Oct 2024 Low |
| 2024 Target 1 | 298.5 (+3%) | Price Action: 26 Nov 2024 High |
| Current Price | 289.80 | Sakar Healthcare's share price as of 26 Dec 2024 |
| Stop Loss 1 | 286.42 (-1.17%) | Price Action: Chart |
| Stop Loss 2 | 283.3 (-2.25%) | Price Action: Dec 2022 High |
| Stop Loss 3 | 280.15 (-3.33%) | Price Action: 22 Nov 2024 Low |
Short-Term Technical Outlook
Current Technical Position: Sakar Healthcare is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹306.53 serves as the nearest technical reference point.
Historical Returns: 3-month: -7.77% | 6-month: -7.81% | 1-year: -27.56%
Sakar Healthcare Share Price Target For 2025
The line chart displays the monthly closing prices of Sakar Healthcare with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Sakar Healthcare shares in 2025, see the table below.
Sakar Healthcare Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 419.05 (+44.59%) | Fibonacci Extension Level 64.90% |
| 2025 Target 2 | 414.1 (+42.89%) | Price Action: 07 Feb 2024 Low |
| 2025 Target 1 | 410.0 (+41.47%) | Price Action: 16 Nov 2023 High |
| Current Price | 289.80 | Sakar Healthcare's share price as of 26 Dec 2024 |
| Stop Loss 1 | 259.75 (-10.37%) | Price Action: 01 Aug 2023 High |
| Stop Loss 2 | 256.8 (-11.39%) | Price Action: 18 Jul 2023 Low |
| Stop Loss 3 | 253.0 (-12.7%) | Price Action: 02 Aug 2023 Low |
Long-Term Technical Outlook
52-Week Range Analysis: Sakar Healthcare is currently trading near its 52-week low of ₹279.85, indicating potential value opportunity.
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -27.56% | 3-year: +78.17% | 5-year: +409.31%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Sakar Healthcare Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹289.80 | ||
| 2024 | ₹312.64 | +7.88% | ₹317.33 |
| 2025 | ₹279.92 | -10.46% | ₹317.68 |
| 2026 | ₹266.02 | -4.96% | ₹293.15 |
| 2027 | ₹239.82 | -9.84% | ₹268.63 |
| 2028 | ₹240.14 | +0.13% | ₹244.10 |
| 2029 | ₹216.58 | -9.81% | ₹225.81 |
| 2030 | ₹188.29 | -13.06% | ₹219.57 |
| 2031 | ₹249.27 | +32.38% | ₹253.01 |
| 2032 | ₹232.84 | -6.59% | ₹256.86 |
| 2033 | ₹242.61 | +4.19% | ₹246.25 |
| 2034 | ₹228.86 | -5.66% | ₹232.29 |
| 2035 | ₹209.40 | -8.5% | ₹232.95 |
| 2036 | ₹203.86 | -2.64% | ₹221.00 |
| 2037 | ₹213.14 | +4.55% | ₹216.34 |
| 2038 | ₹223.17 | +4.7% | ₹226.52 |
| 2039 | ₹320.51 | +43.61% | ₹325.32 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Sakar Healthcare Brief Company Overview
Sakar Healthcare Limited: Overview Incorporated in 2004 and headquartered in Ahmedabad, India, Sakar Healthcare Ltd is a renowned pharmaceutical company that develops, manufactures, and markets a diverse range of pharmaceutical products in India and beyond. The...
company's product portfolio is extensive, covering 22 therapeutic areas. Its products include liquid orals, cephalosporin tablets, dry powder injections, and oral solid dosages. Sakar Healthcare has established a strong market presence, exporting its products to approximately 38 countries across various regions including Southeast Asia, Africa, MENA, and the United States.Sakar Healthcare Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 586.97 Crore | Market valuation of Sakar Healthcare's shares. |
| Revenue (TTM) | 151.77 Crore | Total revenue generated by Sakar Healthcare over the past twelve months. |
| Net Income (TTM) | +12.47 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +12.26% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +8.21% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+11.2% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
-48.3% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
32.48 | Company's total debt divided by total shareholder equity. |
| Total Debt | 76.97 Crore | Sum of Sakar Healthcare's current & long-term financial obligations. |
| Total Cash | 31.61 Lakh | Total amount of liquid funds available to Sakar Healthcare. |
| Beta | 0.51 | Beta is less than 1 indicating that the Sakar Healthcare's price is less volatile than the market. |
Is Sakar Healthcare A Good Buy For Long Term?
Sakar Healthcare, despite facing a decline in earnings lately, has shown consistent growth in the past. With a healthy profit margin of 8.21%, it presents a long-term investment opportunity.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
